These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26040631)

  • 1. Modelling the cost-effectiveness of pharmacotherapy compared with cognitive-behavioural therapy and combination therapy for the treatment of moderate to severe depression in the UK.
    Koeser L; Donisi V; Goldberg DP; McCrone P
    Psychol Med; 2015 Oct; 45(14):3019-31. PubMed ID: 26040631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan.
    Sado M; Knapp M; Yamauchi K; Fujisawa D; So M; Nakagawa A; Kikuchi T; Ono Y
    Aust N Z J Psychiatry; 2009 Jun; 43(6):539-47. PubMed ID: 19440886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depression.
    Vos T; Corry J; Haby MM; Carter R; Andrews G
    Aust N Z J Psychiatry; 2005 Aug; 39(8):683-92. PubMed ID: 16050922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.
    Richards DA; Ekers D; McMillan D; Taylor RS; Byford S; Warren FC; Barrett B; Farrand PA; Gilbody S; Kuyken W; O'Mahen H; Watkins ER; Wright KA; Hollon SD; Reed N; Rhodes S; Fletcher E; Finning K
    Lancet; 2016 Aug; 388(10047):871-80. PubMed ID: 27461440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
    Nguyen KH; Gordon LG
    Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
    Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
    Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States.
    Ross EL; Zivin K; Maixner DF
    JAMA Psychiatry; 2018 Jul; 75(7):713-722. PubMed ID: 29800956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cost-Effectiveness of Cognitive Behavioral Therapy Versus Second-Generation Antidepressants for Initial Treatment of Major Depressive Disorder in the United States: A Decision Analytic Model.
    Ross EL; Vijan S; Miller EM; Valenstein M; Zivin K
    Ann Intern Med; 2019 Dec; 171(11):785-795. PubMed ID: 31658472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial.
    Watanabe N; Furukawa TA; Shimodera S; Katsuki F; Fujita H; Sasaki M; Sado M; Perlis ML
    Psychiatry Clin Neurosci; 2015 Jun; 69(6):335-43. PubMed ID: 25205008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
    Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
    J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT Trial.
    Hollinghurst S; Carroll FE; Abel A; Campbell J; Garland A; Jerrom B; Kessler D; Kuyken W; Morrison J; Ridgway N; Thomas L; Turner K; Williams C; Peters TJ; Lewis G; Wiles N
    Br J Psychiatry; 2014 Jan; 204(1):69-76. PubMed ID: 24262818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Utility Analysis of Mindfulness-Based Cognitive Therapy Versus Antidepressant Pharmacotherapy for Prevention of Depressive Relapse in a Canadian Context: Analyse coût-utilité de la thérapie cognitive basée sur la pleine conscience contre la pharmacothérapie antidépressive pour prévenir la rechute de la dépression en contexte canadien.
    Pahlevan T; Ung C; Segal Z
    Can J Psychiatry; 2020 Aug; 65(8):568-576. PubMed ID: 32031000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of alternative treatments for depression in low-income women.
    Beil H; Beeber LS; Schwartz TA; Lewis G
    J Ment Health Policy Econ; 2013 Jun; 16(2):55-65. PubMed ID: 23999203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of active monitoring versus antidepressants for major depression in primary health care: a 12-month non-randomized controlled trial (INFAP study).
    Rubio-Valera M; Beneitez I; Peñarrubia-María MT; Luciano JV; Mendive JM; McCrone P; Knapp M; Sabés-Figuera R; Kocyan K; García-Campayo J; Serrano-Blanco A
    BMC Psychiatry; 2015 Mar; 15():63. PubMed ID: 25885818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evidence for the clinical management of major depressive disorder: a systematic review and quality appraisal of economic evaluations alongside randomised controlled trials.
    Karyotaki E; Tordrup D; Buntrock C; Bertollini R; Cuijpers P
    Epidemiol Psychiatr Sci; 2017 Oct; 26(5):501-516. PubMed ID: 27328966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis for antidepressants and cognitive behavioral therapy for major depression in Thailand.
    Prukkanone B; Vos T; Bertram M; Lim S
    Value Health; 2012; 15(1 Suppl):S3-8. PubMed ID: 22265064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of cost-effectiveness between offering antidepressant-CBT combinations first or second, for moderate to severe depression in Japan.
    Yamada Y; Miyahara R; Wada M; Ninomiya A; Kosugi T; Mimura M; Sado M
    J Affect Disord; 2021 Sep; 292():574-582. PubMed ID: 34147970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bendamustine versus chlorambucil for the first-line treatment of chronic lymphocytic leukemia in England and Wales: a cost-utility analysis.
    Woods B; Hawkins N; Dunlop W; O'Toole A; Bramham-Jones S
    Value Health; 2012; 15(5):759-70. PubMed ID: 22867787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An economic evaluation of an augmented cognitive behavioural intervention vs. computerized cognitive training for post-stroke depressive symptoms.
    van Eeden M; Kootker JA; Evers SM; van Heugten CM; Geurts AC; van Mastrigt GA
    BMC Neurol; 2015 Dec; 15():266. PubMed ID: 26715040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment options in moderate and severe depression: decision analysis supporting a clinical guideline.
    Simon J; Pilling S; Burbeck R; Goldberg D
    Br J Psychiatry; 2006 Dec; 189():494-501. PubMed ID: 17139032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.